Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial

Transplant Proc. 2002 Aug;34(5):1911-2. doi: 10.1016/s0041-1345(02)03120-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Survival / physiology*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Pancreas Transplantation / immunology*
  • Pancreas Transplantation / mortality
  • Pancreas Transplantation / physiology
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Time Factors
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus